nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxsalen—CYP1A1—Cholecalciferol—osteoporosis	0.118	0.168	CbGbCtD
Methoxsalen—CYP1A2—Estropipate—osteoporosis	0.103	0.146	CbGbCtD
Methoxsalen—CYP1A1—Estradiol—osteoporosis	0.0955	0.135	CbGbCtD
Methoxsalen—CYP3A4—Estropipate—osteoporosis	0.0538	0.0764	CbGbCtD
Methoxsalen—CYP3A4—Calcitriol—osteoporosis	0.0538	0.0764	CbGbCtD
Methoxsalen—CYP1A2—Conjugated Estrogens—osteoporosis	0.0486	0.0689	CbGbCtD
Methoxsalen—CYP3A4—Ergocalciferol—osteoporosis	0.043	0.0611	CbGbCtD
Methoxsalen—CYP1A2—Estradiol—osteoporosis	0.0426	0.0605	CbGbCtD
Methoxsalen—CYP3A4—Raloxifene—osteoporosis	0.0359	0.051	CbGbCtD
Methoxsalen—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0347	0.0492	CbGbCtD
Methoxsalen—CYP3A4—Cholecalciferol—osteoporosis	0.0277	0.0393	CbGbCtD
Methoxsalen—CYP3A4—Conjugated Estrogens—osteoporosis	0.0254	0.0361	CbGbCtD
Methoxsalen—CYP3A4—Estradiol—osteoporosis	0.0223	0.0317	CbGbCtD
Methoxsalen—CYP2A13—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.00245	0.0558	CbGpPWpGaD
Methoxsalen—CYP2A13—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.00241	0.0551	CbGpPWpGaD
Methoxsalen—CYP2A13—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.00198	0.0452	CbGpPWpGaD
Methoxsalen—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.0019	0.0433	CbGpPWpGaD
Methoxsalen—CYP2A13—Tryptophan metabolism—CYP19A1—osteoporosis	0.00159	0.0363	CbGpPWpGaD
Methoxsalen—Depression—Raloxifene—osteoporosis	0.00132	0.00525	CcSEcCtD
Methoxsalen—Depression—Ibandronate—osteoporosis	0.00131	0.0052	CcSEcCtD
Methoxsalen—CYP2A13—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.00129	0.0293	CbGpPWpGaD
Methoxsalen—CYP2A13—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.00127	0.0289	CbGpPWpGaD
Methoxsalen—Feeling abnormal—Calcium Acetate—osteoporosis	0.00127	0.00503	CcSEcCtD
Methoxsalen—Erythema—Etidronic acid—osteoporosis	0.00124	0.00491	CcSEcCtD
Methoxsalen—Skin exfoliation—Estradiol—osteoporosis	0.00124	0.00491	CcSEcCtD
Methoxsalen—Dermatitis bullous—Conjugated Estrogens—osteoporosis	0.00123	0.00488	CcSEcCtD
Methoxsalen—Muscle spasms—Etidronic acid—osteoporosis	0.00119	0.00472	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Estradiol—osteoporosis	0.00119	0.00472	CcSEcCtD
Methoxsalen—Hypersensitivity—Calcium Acetate—osteoporosis	0.00113	0.0045	CcSEcCtD
Methoxsalen—Depression—Ethinyl Estradiol—osteoporosis	0.00111	0.0044	CcSEcCtD
Methoxsalen—Pruritus—Calcium Acetate—osteoporosis	0.00109	0.00432	CcSEcCtD
Methoxsalen—Depression—Risedronate—osteoporosis	0.00108	0.00429	CcSEcCtD
Methoxsalen—Erythema—Estropipate—osteoporosis	0.00107	0.00425	CcSEcCtD
Methoxsalen—Erythema—Alendronate—osteoporosis	0.00105	0.00419	CcSEcCtD
Methoxsalen—CYP2A13—Biological oxidations—CYP27A1—osteoporosis	0.00105	0.024	CbGpPWpGaD
Methoxsalen—Tension—Estropipate—osteoporosis	0.00105	0.00417	CcSEcCtD
Methoxsalen—CYP2A13—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.00104	0.0238	CbGpPWpGaD
Methoxsalen—Discomfort—Etidronic acid—osteoporosis	0.00104	0.00413	CcSEcCtD
Methoxsalen—CYP2A13—Metapathway biotransformation—CYP27A1—osteoporosis	0.00104	0.0237	CbGpPWpGaD
Methoxsalen—Nervousness—Estropipate—osteoporosis	0.00104	0.00413	CcSEcCtD
Methoxsalen—Dysgeusia—Alendronate—osteoporosis	0.00103	0.0041	CcSEcCtD
Methoxsalen—Arrhythmia—Calcitriol—osteoporosis	0.00103	0.00409	CcSEcCtD
Methoxsalen—Muscle spasms—Estropipate—osteoporosis	0.00103	0.00409	CcSEcCtD
Methoxsalen—Erythema—Ibandronate—osteoporosis	0.00103	0.00408	CcSEcCtD
Methoxsalen—Dizziness—Calcium Acetate—osteoporosis	0.00102	0.00404	CcSEcCtD
Methoxsalen—Muscle spasms—Alendronate—osteoporosis	0.00101	0.00403	CcSEcCtD
Methoxsalen—Dysgeusia—Ibandronate—osteoporosis	0.001	0.00399	CcSEcCtD
Methoxsalen—Erythema—Calcitriol—osteoporosis	0.001	0.00399	CcSEcCtD
Methoxsalen—Infection—Etidronic acid—osteoporosis	0.001	0.00398	CcSEcCtD
Methoxsalen—Muscle spasms—Raloxifene—osteoporosis	0.000996	0.00396	CcSEcCtD
Methoxsalen—Muscle spasms—Ibandronate—osteoporosis	0.000986	0.00392	CcSEcCtD
Methoxsalen—Dysgeusia—Calcitriol—osteoporosis	0.000984	0.00391	CcSEcCtD
Methoxsalen—Ill-defined disorder—Alendronate—osteoporosis	0.000978	0.00388	CcSEcCtD
Methoxsalen—Vertigo—Estropipate—osteoporosis	0.000961	0.00382	CcSEcCtD
Methoxsalen—Ill-defined disorder—Ibandronate—osteoporosis	0.000952	0.00378	CcSEcCtD
Methoxsalen—Malaise—Alendronate—osteoporosis	0.00095	0.00378	CcSEcCtD
Methoxsalen—Vertigo—Alendronate—osteoporosis	0.000947	0.00376	CcSEcCtD
Methoxsalen—Depression—Zoledronate—osteoporosis	0.000937	0.00372	CcSEcCtD
Methoxsalen—Vertigo—Raloxifene—osteoporosis	0.000931	0.0037	CcSEcCtD
Methoxsalen—Malaise—Ibandronate—osteoporosis	0.000925	0.00368	CcSEcCtD
Methoxsalen—Vertigo—Ibandronate—osteoporosis	0.000922	0.00366	CcSEcCtD
Methoxsalen—Nausea—Calcium Acetate—osteoporosis	0.000913	0.00363	CcSEcCtD
Methoxsalen—Depression—Conjugated Estrogens—osteoporosis	0.000902	0.00358	CcSEcCtD
Methoxsalen—Dyspepsia—Etidronic acid—osteoporosis	0.000889	0.00353	CcSEcCtD
Methoxsalen—Discomfort—Alendronate—osteoporosis	0.000886	0.00352	CcSEcCtD
Methoxsalen—Oedema—Estropipate—osteoporosis	0.000873	0.00347	CcSEcCtD
Methoxsalen—Arrhythmia—Risedronate—osteoporosis	0.000868	0.00345	CcSEcCtD
Methoxsalen—Infection—Estropipate—osteoporosis	0.000868	0.00345	CcSEcCtD
Methoxsalen—Discomfort—Ibandronate—osteoporosis	0.000863	0.00343	CcSEcCtD
Methoxsalen—Dry skin—Estradiol—osteoporosis	0.000861	0.00342	CcSEcCtD
Methoxsalen—Infection—Alendronate—osteoporosis	0.000854	0.00339	CcSEcCtD
Methoxsalen—Skin disorder—Estropipate—osteoporosis	0.000848	0.00337	CcSEcCtD
Methoxsalen—Discomfort—Calcitriol—osteoporosis	0.000845	0.00336	CcSEcCtD
Methoxsalen—Infection—Raloxifene—osteoporosis	0.00084	0.00334	CcSEcCtD
Methoxsalen—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.000834	0.00331	CcSEcCtD
Methoxsalen—Infection—Ibandronate—osteoporosis	0.000832	0.00331	CcSEcCtD
Methoxsalen—Feeling abnormal—Etidronic acid—osteoporosis	0.000832	0.0033	CcSEcCtD
Methoxsalen—Skin disorder—Raloxifene—osteoporosis	0.000822	0.00326	CcSEcCtD
Methoxsalen—Skin disorder—Ibandronate—osteoporosis	0.000813	0.00323	CcSEcCtD
Methoxsalen—Muscle spasms—Risedronate—osteoporosis	0.000813	0.00323	CcSEcCtD
Methoxsalen—Nausea—Ergocalciferol—osteoporosis	0.000807	0.0032	CcSEcCtD
Methoxsalen—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.000805	0.0032	CcSEcCtD
Methoxsalen—Erythema—Pamidronate—osteoporosis	0.000804	0.00319	CcSEcCtD
Methoxsalen—Urticaria—Etidronic acid—osteoporosis	0.000802	0.00319	CcSEcCtD
Methoxsalen—Skin disorder—Calcitriol—osteoporosis	0.000796	0.00316	CcSEcCtD
Methoxsalen—Insomnia—Estropipate—osteoporosis	0.00079	0.00314	CcSEcCtD
Methoxsalen—Tension—Pamidronate—osteoporosis	0.000789	0.00313	CcSEcCtD
Methoxsalen—Dysgeusia—Pamidronate—osteoporosis	0.000787	0.00313	CcSEcCtD
Methoxsalen—Malaise—Ethinyl Estradiol—osteoporosis	0.000782	0.00311	CcSEcCtD
Methoxsalen—Nervousness—Pamidronate—osteoporosis	0.000781	0.0031	CcSEcCtD
Methoxsalen—Muscle spasms—Pamidronate—osteoporosis	0.000773	0.00307	CcSEcCtD
Methoxsalen—CYP2A13—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000773	0.0176	CbGpPWpGaD
Methoxsalen—Dyspepsia—Estropipate—osteoporosis	0.000769	0.00305	CcSEcCtD
Methoxsalen—Insomnia—Raloxifene—osteoporosis	0.000765	0.00304	CcSEcCtD
Methoxsalen—Vertigo—Risedronate—osteoporosis	0.00076	0.00302	CcSEcCtD
Methoxsalen—Insomnia—Ibandronate—osteoporosis	0.000757	0.00301	CcSEcCtD
Methoxsalen—Dyspepsia—Alendronate—osteoporosis	0.000757	0.00301	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Estropipate—osteoporosis	0.000754	0.003	CcSEcCtD
Methoxsalen—Arrhythmia—Zoledronate—osteoporosis	0.000753	0.00299	CcSEcCtD
Methoxsalen—Ill-defined disorder—Pamidronate—osteoporosis	0.000746	0.00296	CcSEcCtD
Methoxsalen—Dyspepsia—Raloxifene—osteoporosis	0.000745	0.00296	CcSEcCtD
Methoxsalen—Hypersensitivity—Etidronic acid—osteoporosis	0.000744	0.00295	CcSEcCtD
Methoxsalen—Insomnia—Calcitriol—osteoporosis	0.000741	0.00295	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Estradiol—osteoporosis	0.000741	0.00294	CcSEcCtD
Methoxsalen—Dyspepsia—Ibandronate—osteoporosis	0.000737	0.00293	CcSEcCtD
Methoxsalen—Erythema—Zoledronate—osteoporosis	0.000734	0.00292	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00073	0.0029	CcSEcCtD
Methoxsalen—Discomfort—Ethinyl Estradiol—osteoporosis	0.000729	0.0029	CcSEcCtD
Methoxsalen—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000726	0.00288	CcSEcCtD
Methoxsalen—Malaise—Pamidronate—osteoporosis	0.000725	0.00288	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000723	0.00287	CcSEcCtD
Methoxsalen—Depression—Estradiol—osteoporosis	0.000722	0.00287	CcSEcCtD
Methoxsalen—Dysgeusia—Zoledronate—osteoporosis	0.000719	0.00286	CcSEcCtD
Methoxsalen—Pruritus—Etidronic acid—osteoporosis	0.000714	0.00284	CcSEcCtD
Methoxsalen—Feeling abnormal—Alendronate—osteoporosis	0.000709	0.00282	CcSEcCtD
Methoxsalen—Oedema—Ethinyl Estradiol—osteoporosis	0.000708	0.00281	CcSEcCtD
Methoxsalen—Erythema—Conjugated Estrogens—osteoporosis	0.000707	0.00281	CcSEcCtD
Methoxsalen—Muscle spasms—Zoledronate—osteoporosis	0.000706	0.0028	CcSEcCtD
Methoxsalen—Infection—Ethinyl Estradiol—osteoporosis	0.000703	0.00279	CcSEcCtD
Methoxsalen—Tension—Conjugated Estrogens—osteoporosis	0.000694	0.00276	CcSEcCtD
Methoxsalen—Urticaria—Estropipate—osteoporosis	0.000694	0.00276	CcSEcCtD
Methoxsalen—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000692	0.00275	CcSEcCtD
Methoxsalen—Body temperature increased—Estropipate—osteoporosis	0.00069	0.00274	CcSEcCtD
Methoxsalen—Feeling abnormal—Ibandronate—osteoporosis	0.00069	0.00274	CcSEcCtD
Methoxsalen—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000688	0.00273	CcSEcCtD
Methoxsalen—Nervousness—Conjugated Estrogens—osteoporosis	0.000687	0.00273	CcSEcCtD
Methoxsalen—Infection—Risedronate—osteoporosis	0.000686	0.00272	CcSEcCtD
Methoxsalen—Urticaria—Alendronate—osteoporosis	0.000683	0.00271	CcSEcCtD
Methoxsalen—Ill-defined disorder—Zoledronate—osteoporosis	0.000681	0.00271	CcSEcCtD
Methoxsalen—Body temperature increased—Alendronate—osteoporosis	0.00068	0.0027	CcSEcCtD
Methoxsalen—Muscle spasms—Conjugated Estrogens—osteoporosis	0.00068	0.0027	CcSEcCtD
Methoxsalen—Discomfort—Pamidronate—osteoporosis	0.000676	0.00269	CcSEcCtD
Methoxsalen—Skin disorder—Risedronate—osteoporosis	0.00067	0.00266	CcSEcCtD
Methoxsalen—Body temperature increased—Raloxifene—osteoporosis	0.000669	0.00266	CcSEcCtD
Methoxsalen—Urticaria—Ibandronate—osteoporosis	0.000665	0.00264	CcSEcCtD
Methoxsalen—Malaise—Zoledronate—osteoporosis	0.000662	0.00263	CcSEcCtD
Methoxsalen—Body temperature increased—Ibandronate—osteoporosis	0.000662	0.00263	CcSEcCtD
Methoxsalen—Vertigo—Zoledronate—osteoporosis	0.00066	0.00262	CcSEcCtD
Methoxsalen—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000656	0.015	CbGpPWpGaD
Methoxsalen—Oedema—Pamidronate—osteoporosis	0.000656	0.00261	CcSEcCtD
Methoxsalen—Infection—Pamidronate—osteoporosis	0.000652	0.00259	CcSEcCtD
Methoxsalen—Urticaria—Calcitriol—osteoporosis	0.000651	0.00259	CcSEcCtD
Methoxsalen—Body temperature increased—Calcitriol—osteoporosis	0.000648	0.00257	CcSEcCtD
Methoxsalen—CYP2A6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000648	0.0148	CbGpPWpGaD
Methoxsalen—Hypersensitivity—Estropipate—osteoporosis	0.000643	0.00256	CcSEcCtD
Methoxsalen—Rash—Etidronic acid—osteoporosis	0.000636	0.00253	CcSEcCtD
Methoxsalen—Dermatitis—Etidronic acid—osteoporosis	0.000636	0.00253	CcSEcCtD
Methoxsalen—Vertigo—Conjugated Estrogens—osteoporosis	0.000635	0.00252	CcSEcCtD
Methoxsalen—Hypersensitivity—Alendronate—osteoporosis	0.000634	0.00252	CcSEcCtD
Methoxsalen—Headache—Etidronic acid—osteoporosis	0.000632	0.00251	CcSEcCtD
Methoxsalen—CYP2A13—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000626	0.0143	CbGpPWpGaD
Methoxsalen—Insomnia—Risedronate—osteoporosis	0.000624	0.00248	CcSEcCtD
Methoxsalen—Pruritus—Estropipate—osteoporosis	0.000618	0.00245	CcSEcCtD
Methoxsalen—Discomfort—Zoledronate—osteoporosis	0.000618	0.00245	CcSEcCtD
Methoxsalen—Hypersensitivity—Ibandronate—osteoporosis	0.000617	0.00245	CcSEcCtD
Methoxsalen—Hypotension—Pamidronate—osteoporosis	0.000613	0.00244	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000611	0.00243	CcSEcCtD
Methoxsalen—Pruritus—Alendronate—osteoporosis	0.000608	0.00242	CcSEcCtD
Methoxsalen—Dyspepsia—Risedronate—osteoporosis	0.000607	0.00241	CcSEcCtD
Methoxsalen—Hypersensitivity—Calcitriol—osteoporosis	0.000604	0.0024	CcSEcCtD
Methoxsalen—Nausea—Etidronic acid—osteoporosis	0.0006	0.00238	CcSEcCtD
Methoxsalen—Oedema—Zoledronate—osteoporosis	0.000599	0.00238	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Risedronate—osteoporosis	0.000596	0.00237	CcSEcCtD
Methoxsalen—Infection—Zoledronate—osteoporosis	0.000595	0.00237	CcSEcCtD
Methoxsalen—Insomnia—Pamidronate—osteoporosis	0.000593	0.00236	CcSEcCtD
Methoxsalen—Pruritus—Ibandronate—osteoporosis	0.000592	0.00235	CcSEcCtD
Methoxsalen—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000583	0.00232	CcSEcCtD
Methoxsalen—CYP1A1—Estrogen Receptor Pathway—ESR1—osteoporosis	0.000583	0.0133	CbGpPWpGaD
Methoxsalen—Skin disorder—Zoledronate—osteoporosis	0.000582	0.00231	CcSEcCtD
Methoxsalen—Pruritus—Calcitriol—osteoporosis	0.00058	0.0023	CcSEcCtD
Methoxsalen—Dyspepsia—Pamidronate—osteoporosis	0.000577	0.00229	CcSEcCtD
Methoxsalen—Dizziness—Estropipate—osteoporosis	0.000577	0.00229	CcSEcCtD
Methoxsalen—Oedema—Conjugated Estrogens—osteoporosis	0.000577	0.00229	CcSEcCtD
Methoxsalen—Infection—Conjugated Estrogens—osteoporosis	0.000573	0.00228	CcSEcCtD
Methoxsalen—Dizziness—Alendronate—osteoporosis	0.000569	0.00226	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000566	0.00225	CcSEcCtD
Methoxsalen—Erythema—Estradiol—osteoporosis	0.000566	0.00225	CcSEcCtD
Methoxsalen—Urticaria—Ethinyl Estradiol—osteoporosis	0.000562	0.00223	CcSEcCtD
Methoxsalen—Skin disorder—Conjugated Estrogens—osteoporosis	0.00056	0.00223	CcSEcCtD
Methoxsalen—Hypotension—Zoledronate—osteoporosis	0.00056	0.00222	CcSEcCtD
Methoxsalen—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00056	0.00222	CcSEcCtD
Methoxsalen—Dizziness—Raloxifene—osteoporosis	0.000559	0.00222	CcSEcCtD
Methoxsalen—Tension—Estradiol—osteoporosis	0.000555	0.00221	CcSEcCtD
Methoxsalen—Dysgeusia—Estradiol—osteoporosis	0.000554	0.0022	CcSEcCtD
Methoxsalen—Dizziness—Ibandronate—osteoporosis	0.000554	0.0022	CcSEcCtD
Methoxsalen—CYP2A13—Biological oxidations—CYP19A1—osteoporosis	0.000554	0.0126	CbGpPWpGaD
Methoxsalen—Rash—Estropipate—osteoporosis	0.000551	0.00219	CcSEcCtD
Methoxsalen—Dermatitis—Estropipate—osteoporosis	0.00055	0.00219	CcSEcCtD
Methoxsalen—Nervousness—Estradiol—osteoporosis	0.00055	0.00218	CcSEcCtD
Methoxsalen—Urticaria—Risedronate—osteoporosis	0.000548	0.00218	CcSEcCtD
Methoxsalen—Headache—Estropipate—osteoporosis	0.000547	0.00217	CcSEcCtD
Methoxsalen—CYP2A13—Metapathway biotransformation—CYP19A1—osteoporosis	0.000546	0.0125	CbGpPWpGaD
Methoxsalen—Body temperature increased—Risedronate—osteoporosis	0.000546	0.00217	CcSEcCtD
Methoxsalen—Muscle spasms—Estradiol—osteoporosis	0.000544	0.00216	CcSEcCtD
Methoxsalen—Rash—Alendronate—osteoporosis	0.000542	0.00215	CcSEcCtD
Methoxsalen—Insomnia—Zoledronate—osteoporosis	0.000542	0.00215	CcSEcCtD
Methoxsalen—Dermatitis—Alendronate—osteoporosis	0.000542	0.00215	CcSEcCtD
Methoxsalen—Feeling abnormal—Pamidronate—osteoporosis	0.000541	0.00215	CcSEcCtD
Methoxsalen—Hypotension—Conjugated Estrogens—osteoporosis	0.000539	0.00214	CcSEcCtD
Methoxsalen—Headache—Alendronate—osteoporosis	0.000539	0.00214	CcSEcCtD
Methoxsalen—Rash—Raloxifene—osteoporosis	0.000533	0.00212	CcSEcCtD
Methoxsalen—Dermatitis—Raloxifene—osteoporosis	0.000533	0.00212	CcSEcCtD
Methoxsalen—CYP2A6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000532	0.0121	CbGpPWpGaD
Methoxsalen—Headache—Raloxifene—osteoporosis	0.00053	0.00211	CcSEcCtD
Methoxsalen—Rash—Ibandronate—osteoporosis	0.000528	0.0021	CcSEcCtD
Methoxsalen—Dermatitis—Ibandronate—osteoporosis	0.000527	0.0021	CcSEcCtD
Methoxsalen—Dyspepsia—Zoledronate—osteoporosis	0.000527	0.0021	CcSEcCtD
Methoxsalen—Ill-defined disorder—Estradiol—osteoporosis	0.000525	0.00209	CcSEcCtD
Methoxsalen—Headache—Ibandronate—osteoporosis	0.000525	0.00208	CcSEcCtD
Methoxsalen—Insomnia—Conjugated Estrogens—osteoporosis	0.000522	0.00207	CcSEcCtD
Methoxsalen—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000521	0.00207	CcSEcCtD
Methoxsalen—Nausea—Estropipate—osteoporosis	0.000519	0.00206	CcSEcCtD
Methoxsalen—Body temperature increased—Pamidronate—osteoporosis	0.000519	0.00206	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000517	0.00206	CcSEcCtD
Methoxsalen—Rash—Calcitriol—osteoporosis	0.000517	0.00205	CcSEcCtD
Methoxsalen—Dermatitis—Calcitriol—osteoporosis	0.000516	0.00205	CcSEcCtD
Methoxsalen—Headache—Calcitriol—osteoporosis	0.000514	0.00204	CcSEcCtD
Methoxsalen—Nausea—Alendronate—osteoporosis	0.000511	0.00203	CcSEcCtD
Methoxsalen—Malaise—Estradiol—osteoporosis	0.00051	0.00203	CcSEcCtD
Methoxsalen—Hypersensitivity—Risedronate—osteoporosis	0.000508	0.00202	CcSEcCtD
Methoxsalen—Vertigo—Estradiol—osteoporosis	0.000508	0.00202	CcSEcCtD
Methoxsalen—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000508	0.00202	CcSEcCtD
Methoxsalen—Nausea—Raloxifene—osteoporosis	0.000502	0.002	CcSEcCtD
Methoxsalen—Pruritus—Ethinyl Estradiol—osteoporosis	0.000501	0.00199	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000498	0.00198	CcSEcCtD
Methoxsalen—Nausea—Ibandronate—osteoporosis	0.000497	0.00198	CcSEcCtD
Methoxsalen—Feeling abnormal—Zoledronate—osteoporosis	0.000494	0.00196	CcSEcCtD
Methoxsalen—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000489	0.0112	CbGpPWpGaD
Methoxsalen—Pruritus—Risedronate—osteoporosis	0.000488	0.00194	CcSEcCtD
Methoxsalen—Nausea—Calcitriol—osteoporosis	0.000487	0.00193	CcSEcCtD
Methoxsalen—Hypersensitivity—Pamidronate—osteoporosis	0.000483	0.00192	CcSEcCtD
Methoxsalen—CYP1A1—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000483	0.011	CbGpPWpGaD
Methoxsalen—Urticaria—Zoledronate—osteoporosis	0.000476	0.00189	CcSEcCtD
Methoxsalen—Discomfort—Estradiol—osteoporosis	0.000476	0.00189	CcSEcCtD
Methoxsalen—Body temperature increased—Zoledronate—osteoporosis	0.000474	0.00188	CcSEcCtD
Methoxsalen—Dizziness—Ethinyl Estradiol—osteoporosis	0.000468	0.00186	CcSEcCtD
Methoxsalen—Pruritus—Pamidronate—osteoporosis	0.000464	0.00184	CcSEcCtD
Methoxsalen—Oedema—Estradiol—osteoporosis	0.000462	0.00183	CcSEcCtD
Methoxsalen—Infection—Estradiol—osteoporosis	0.000459	0.00182	CcSEcCtD
Methoxsalen—Urticaria—Conjugated Estrogens—osteoporosis	0.000458	0.00182	CcSEcCtD
Methoxsalen—Dizziness—Risedronate—osteoporosis	0.000456	0.00181	CcSEcCtD
Methoxsalen—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000456	0.00181	CcSEcCtD
Methoxsalen—Skin disorder—Estradiol—osteoporosis	0.000449	0.00178	CcSEcCtD
Methoxsalen—Rash—Ethinyl Estradiol—osteoporosis	0.000446	0.00177	CcSEcCtD
Methoxsalen—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000446	0.00177	CcSEcCtD
Methoxsalen—Headache—Ethinyl Estradiol—osteoporosis	0.000443	0.00176	CcSEcCtD
Methoxsalen—Hypersensitivity—Zoledronate—osteoporosis	0.000441	0.00175	CcSEcCtD
Methoxsalen—Rash—Risedronate—osteoporosis	0.000435	0.00173	CcSEcCtD
Methoxsalen—Dermatitis—Risedronate—osteoporosis	0.000435	0.00173	CcSEcCtD
Methoxsalen—Dizziness—Pamidronate—osteoporosis	0.000434	0.00172	CcSEcCtD
Methoxsalen—Headache—Risedronate—osteoporosis	0.000432	0.00172	CcSEcCtD
Methoxsalen—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000425	0.00169	CcSEcCtD
Methoxsalen—Pruritus—Zoledronate—osteoporosis	0.000424	0.00168	CcSEcCtD
Methoxsalen—Nausea—Ethinyl Estradiol—osteoporosis	0.00042	0.00167	CcSEcCtD
Methoxsalen—CYP2A6—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.000418	0.00953	CbGpPWpGaD
Methoxsalen—Insomnia—Estradiol—osteoporosis	0.000418	0.00166	CcSEcCtD
Methoxsalen—Rash—Pamidronate—osteoporosis	0.000414	0.00164	CcSEcCtD
Methoxsalen—Dermatitis—Pamidronate—osteoporosis	0.000413	0.00164	CcSEcCtD
Methoxsalen—Headache—Pamidronate—osteoporosis	0.000411	0.00163	CcSEcCtD
Methoxsalen—Nausea—Risedronate—osteoporosis	0.00041	0.00163	CcSEcCtD
Methoxsalen—Pruritus—Conjugated Estrogens—osteoporosis	0.000408	0.00162	CcSEcCtD
Methoxsalen—Dyspepsia—Estradiol—osteoporosis	0.000406	0.00161	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Estradiol—osteoporosis	0.000399	0.00158	CcSEcCtD
Methoxsalen—CYP1A1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000396	0.00904	CbGpPWpGaD
Methoxsalen—Dizziness—Zoledronate—osteoporosis	0.000396	0.00157	CcSEcCtD
Methoxsalen—Nausea—Pamidronate—osteoporosis	0.00039	0.00155	CcSEcCtD
Methoxsalen—CYP1A1—Oxidative Stress—SOD2—osteoporosis	0.000382	0.00871	CbGpPWpGaD
Methoxsalen—Dizziness—Conjugated Estrogens—osteoporosis	0.000382	0.00152	CcSEcCtD
Methoxsalen—Feeling abnormal—Estradiol—osteoporosis	0.000381	0.00151	CcSEcCtD
Methoxsalen—Rash—Zoledronate—osteoporosis	0.000378	0.0015	CcSEcCtD
Methoxsalen—Dermatitis—Zoledronate—osteoporosis	0.000377	0.0015	CcSEcCtD
Methoxsalen—Headache—Zoledronate—osteoporosis	0.000375	0.00149	CcSEcCtD
Methoxsalen—CYP1A2—Estrogen Receptor Pathway—ESR1—osteoporosis	0.000372	0.00848	CbGpPWpGaD
Methoxsalen—Urticaria—Estradiol—osteoporosis	0.000367	0.00146	CcSEcCtD
Methoxsalen—Body temperature increased—Estradiol—osteoporosis	0.000365	0.00145	CcSEcCtD
Methoxsalen—CYP1A1—Oxidative Stress—GPX1—osteoporosis	0.000364	0.00831	CbGpPWpGaD
Methoxsalen—Rash—Conjugated Estrogens—osteoporosis	0.000364	0.00145	CcSEcCtD
Methoxsalen—Dermatitis—Conjugated Estrogens—osteoporosis	0.000363	0.00144	CcSEcCtD
Methoxsalen—Headache—Conjugated Estrogens—osteoporosis	0.000361	0.00144	CcSEcCtD
Methoxsalen—Nausea—Zoledronate—osteoporosis	0.000356	0.00141	CcSEcCtD
Methoxsalen—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000345	0.00786	CbGpPWpGaD
Methoxsalen—Nausea—Conjugated Estrogens—osteoporosis	0.000343	0.00136	CcSEcCtD
Methoxsalen—CYP2A6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.00034	0.00776	CbGpPWpGaD
Methoxsalen—Hypersensitivity—Estradiol—osteoporosis	0.00034	0.00135	CcSEcCtD
Methoxsalen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—GPD2—osteoporosis	0.000335	0.00765	CbGpPWpGaD
Methoxsalen—CYP2A13—Biological oxidations—POMC—osteoporosis	0.000333	0.00759	CbGpPWpGaD
Methoxsalen—Pruritus—Estradiol—osteoporosis	0.000327	0.0013	CcSEcCtD
Methoxsalen—CYP1A1—Tryptophan metabolism—CYP19A1—osteoporosis	0.000318	0.00725	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—PKM—osteoporosis	0.000314	0.00716	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—FDPS—osteoporosis	0.000314	0.00716	CbGpPWpGaD
Methoxsalen—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000312	0.00711	CbGpPWpGaD
Methoxsalen—CYP1A2—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000308	0.00702	CbGpPWpGaD
Methoxsalen—Dizziness—Estradiol—osteoporosis	0.000305	0.00121	CcSEcCtD
Methoxsalen—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000303	0.00691	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—GPD2—osteoporosis	0.000297	0.00678	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—PGLS—osteoporosis	0.000297	0.00678	CbGpPWpGaD
Methoxsalen—Rash—Estradiol—osteoporosis	0.000291	0.00116	CcSEcCtD
Methoxsalen—Dermatitis—Estradiol—osteoporosis	0.000291	0.00116	CcSEcCtD
Methoxsalen—Headache—Estradiol—osteoporosis	0.000289	0.00115	CcSEcCtD
Methoxsalen—CYP2A6—Biological oxidations—CYP27A1—osteoporosis	0.000283	0.00645	CbGpPWpGaD
Methoxsalen—CYP2A6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.00028	0.00638	CbGpPWpGaD
Methoxsalen—Nausea—Estradiol—osteoporosis	0.000274	0.00109	CcSEcCtD
Methoxsalen—CYP2A13—Metabolism—PNP—osteoporosis	0.000272	0.0062	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—ATIC—osteoporosis	0.000272	0.0062	CbGpPWpGaD
Methoxsalen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—OXCT1—osteoporosis	0.000261	0.00595	CbGpPWpGaD
Methoxsalen—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000257	0.00586	CbGpPWpGaD
Methoxsalen—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000254	0.00578	CbGpPWpGaD
Methoxsalen—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000253	0.00577	CbGpPWpGaD
Methoxsalen—CYP1A1—Arachidonic acid metabolism—GPX1—osteoporosis	0.000242	0.00552	CbGpPWpGaD
Methoxsalen—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000241	0.00549	CbGpPWpGaD
Methoxsalen—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000237	0.00542	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—CA2—osteoporosis	0.000231	0.00528	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—OXCT1—osteoporosis	0.000231	0.00528	CbGpPWpGaD
Methoxsalen—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000227	0.00517	CbGpPWpGaD
Methoxsalen—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000226	0.00514	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—MGLL—osteoporosis	0.000225	0.00514	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	0.000212	0.00484	CbGpPWpGaD
Methoxsalen—CYP1A1—Biological oxidations—CYP27A1—osteoporosis	0.000211	0.0048	CbGpPWpGaD
Methoxsalen—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000208	0.00475	CbGpPWpGaD
Methoxsalen—CYP1A1—Metapathway biotransformation—CYP27A1—osteoporosis	0.000208	0.00474	CbGpPWpGaD
Methoxsalen—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000207	0.00473	CbGpPWpGaD
Methoxsalen—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	0.000203	0.00462	CbGpPWpGaD
Methoxsalen—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000195	0.00445	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—IDH2—osteoporosis	0.000192	0.00437	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—CYP27A1—osteoporosis	0.00018	0.00411	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—ACP5—osteoporosis	0.000175	0.004	CbGpPWpGaD
Methoxsalen—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000174	0.00397	CbGpPWpGaD
Methoxsalen—CYP2A6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000168	0.00383	CbGpPWpGaD
Methoxsalen—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000164	0.00374	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—TPI1—osteoporosis	0.000163	0.00372	CbGpPWpGaD
Methoxsalen—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000162	0.00369	CbGpPWpGaD
Methoxsalen—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000156	0.00357	CbGpPWpGaD
Methoxsalen—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000154	0.00352	CbGpPWpGaD
Methoxsalen—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	0.000154	0.00352	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—P4HB—osteoporosis	0.000153	0.00349	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—GAPDH—osteoporosis	0.00015	0.00343	CbGpPWpGaD
Methoxsalen—CYP2A6—Biological oxidations—CYP19A1—osteoporosis	0.000148	0.00339	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—RAP1A—osteoporosis	0.000146	0.00334	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	0.000142	0.00323	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000141	0.00321	CbGpPWpGaD
Methoxsalen—CYP2A6—NRF2 pathway—AGER—osteoporosis	0.000139	0.00317	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	0.000135	0.00309	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	0.000134	0.00306	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000133	0.00304	CbGpPWpGaD
Methoxsalen—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000133	0.00303	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	0.000132	0.00302	CbGpPWpGaD
Methoxsalen—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000126	0.00288	CbGpPWpGaD
Methoxsalen—CYP1A1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000125	0.00285	CbGpPWpGaD
Methoxsalen—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000125	0.00285	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—ENO1—osteoporosis	0.000118	0.0027	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—PSMA5—osteoporosis	0.000117	0.00266	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—PSMA2—osteoporosis	0.000117	0.00266	CbGpPWpGaD
Methoxsalen—CYP1A1—Biological oxidations—CYP19A1—osteoporosis	0.000111	0.00252	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.00011	0.00252	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	0.00011	0.00251	CbGpPWpGaD
Methoxsalen—CYP1A1—Metapathway biotransformation—CYP19A1—osteoporosis	0.000109	0.00249	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000104	0.00237	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000104	0.00236	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	0.000103	0.00235	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—TNF—osteoporosis	0.000103	0.00235	CbGpPWpGaD
Methoxsalen—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000102	0.00234	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000102	0.00233	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000101	0.00231	CbGpPWpGaD
Methoxsalen—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	9.84e-05	0.00225	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—CYP19A1—osteoporosis	9.47e-05	0.00216	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	9.04e-05	0.00206	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	8.98e-05	0.00205	CbGpPWpGaD
Methoxsalen—CYP2A6—Biological oxidations—POMC—osteoporosis	8.92e-05	0.00204	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	8.51e-05	0.00194	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PKM—osteoporosis	8.42e-05	0.00192	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—FDPS—osteoporosis	8.42e-05	0.00192	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	8.09e-05	0.00184	CbGpPWpGaD
Methoxsalen—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.98e-05	0.00182	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PGLS—osteoporosis	7.98e-05	0.00182	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GPD2—osteoporosis	7.98e-05	0.00182	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—ADCY5—osteoporosis	7.73e-05	0.00176	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—GPX1—osteoporosis	7.71e-05	0.00176	CbGpPWpGaD
Methoxsalen—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.6e-05	0.00173	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PNP—osteoporosis	7.3e-05	0.00166	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ATIC—osteoporosis	7.3e-05	0.00166	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—MTHFR—osteoporosis	7.11e-05	0.00162	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	7.05e-05	0.00161	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	7.04e-05	0.00161	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	7.02e-05	0.0016	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	6.96e-05	0.00159	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.88e-05	0.00157	CbGpPWpGaD
Methoxsalen—CYP1A1—Biological oxidations—POMC—osteoporosis	6.65e-05	0.00152	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.62e-05	0.00151	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	6.56e-05	0.0015	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	6.56e-05	0.0015	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.45e-05	0.00147	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—FDPS—osteoporosis	6.27e-05	0.00143	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PKM—osteoporosis	6.27e-05	0.00143	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CA2—osteoporosis	6.2e-05	0.00142	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—OXCT1—osteoporosis	6.2e-05	0.00142	CbGpPWpGaD
Methoxsalen—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.16e-05	0.0014	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—MGLL—osteoporosis	6.05e-05	0.00138	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PGLS—osteoporosis	5.94e-05	0.00136	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GPD2—osteoporosis	5.94e-05	0.00136	CbGpPWpGaD
Methoxsalen—CYP2A6—NRF2 pathway—TGFB1—osteoporosis	5.87e-05	0.00134	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—POMC—osteoporosis	5.69e-05	0.0013	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	5.44e-05	0.00124	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PNP—osteoporosis	5.44e-05	0.00124	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ATIC—osteoporosis	5.44e-05	0.00124	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	5.37e-05	0.00122	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.16e-05	0.00118	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—IDH2—osteoporosis	5.14e-05	0.00117	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CYP27A1—osteoporosis	4.83e-05	0.0011	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ACP5—osteoporosis	4.7e-05	0.00107	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—OXCT1—osteoporosis	4.62e-05	0.00105	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CA2—osteoporosis	4.62e-05	0.00105	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—MGLL—osteoporosis	4.51e-05	0.00103	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.38e-05	0.001	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—TPI1—osteoporosis	4.37e-05	0.000997	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.25e-05	0.000969	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—POMC—osteoporosis	4.24e-05	0.000967	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—P4HB—osteoporosis	4.11e-05	0.000937	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GAPDH—osteoporosis	4.03e-05	0.00092	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PKM—osteoporosis	4e-05	0.000912	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—FDPS—osteoporosis	4e-05	0.000912	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—RAP1A—osteoporosis	3.93e-05	0.000896	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—IDH2—osteoporosis	3.83e-05	0.000874	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PGLS—osteoporosis	3.79e-05	0.000865	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GPD2—osteoporosis	3.79e-05	0.000865	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CYP27A1—osteoporosis	3.6e-05	0.000821	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ACP5—osteoporosis	3.5e-05	0.000799	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ATIC—osteoporosis	3.47e-05	0.000791	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PNP—osteoporosis	3.47e-05	0.000791	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.46e-05	0.000789	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—POMC—osteoporosis	3.27e-05	0.000746	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—TPI1—osteoporosis	3.26e-05	0.000743	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ENO1—osteoporosis	3.18e-05	0.000724	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PSMA2—osteoporosis	3.13e-05	0.000714	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PSMA5—osteoporosis	3.13e-05	0.000714	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PKM—osteoporosis	3.09e-05	0.000704	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—FDPS—osteoporosis	3.09e-05	0.000704	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—P4HB—osteoporosis	3.06e-05	0.000698	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GAPDH—osteoporosis	3.01e-05	0.000686	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CA2—osteoporosis	2.95e-05	0.000672	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—OXCT1—osteoporosis	2.95e-05	0.000672	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—RAP1A—osteoporosis	2.93e-05	0.000668	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PGLS—osteoporosis	2.93e-05	0.000667	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GPD2—osteoporosis	2.93e-05	0.000667	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—MGLL—osteoporosis	2.87e-05	0.000655	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.71e-05	0.000618	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ATIC—osteoporosis	2.68e-05	0.00061	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PNP—osteoporosis	2.68e-05	0.00061	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.55e-05	0.000582	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CYP19A1—osteoporosis	2.54e-05	0.000579	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—IDH2—osteoporosis	2.44e-05	0.000557	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ENO1—osteoporosis	2.37e-05	0.00054	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PSMA2—osteoporosis	2.33e-05	0.000532	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PSMA5—osteoporosis	2.33e-05	0.000532	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP27A1—osteoporosis	2.3e-05	0.000524	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—OXCT1—osteoporosis	2.27e-05	0.000519	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CA2—osteoporosis	2.27e-05	0.000519	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ACP5—osteoporosis	2.23e-05	0.00051	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—MGLL—osteoporosis	2.22e-05	0.000506	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.21e-05	0.000503	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—TPI1—osteoporosis	2.08e-05	0.000474	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ADCY5—osteoporosis	2.07e-05	0.000473	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GPX1—osteoporosis	2.07e-05	0.000472	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—P4HB—osteoporosis	1.95e-05	0.000445	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GAPDH—osteoporosis	1.92e-05	0.000437	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—MTHFR—osteoporosis	1.91e-05	0.000435	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CYP19A1—osteoporosis	1.89e-05	0.000432	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—IDH2—osteoporosis	1.88e-05	0.00043	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—RAP1A—osteoporosis	1.87e-05	0.000426	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.77e-05	0.000404	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ACP5—osteoporosis	1.72e-05	0.000393	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.63e-05	0.000371	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—TPI1—osteoporosis	1.6e-05	0.000366	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ADCY5—osteoporosis	1.55e-05	0.000353	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GPX1—osteoporosis	1.54e-05	0.000351	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—POMC—osteoporosis	1.53e-05	0.000348	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ENO1—osteoporosis	1.51e-05	0.000344	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—P4HB—osteoporosis	1.51e-05	0.000344	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PSMA2—osteoporosis	1.49e-05	0.000339	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PSMA5—osteoporosis	1.49e-05	0.000339	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GAPDH—osteoporosis	1.48e-05	0.000337	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—RAP1A—osteoporosis	1.44e-05	0.000329	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—MTHFR—osteoporosis	1.42e-05	0.000324	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.21e-05	0.000275	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ENO1—osteoporosis	1.16e-05	0.000266	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PSMA2—osteoporosis	1.15e-05	0.000262	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PSMA5—osteoporosis	1.15e-05	0.000262	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—POMC—osteoporosis	1.14e-05	0.000259	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ADCY5—osteoporosis	9.86e-06	0.000225	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GPX1—osteoporosis	9.82e-06	0.000224	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP19A1—osteoporosis	9.31e-06	0.000212	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—MTHFR—osteoporosis	9.06e-06	0.000207	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ADCY5—osteoporosis	7.61e-06	0.000174	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GPX1—osteoporosis	7.58e-06	0.000173	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—POMC—osteoporosis	7.25e-06	0.000165	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—MTHFR—osteoporosis	7e-06	0.00016	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—POMC—osteoporosis	5.6e-06	0.000128	CbGpPWpGaD
